Intuitive Surgical (ISRG) Tops Q2 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz, easing supply
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
RBC Capital Reiterates Outperform Rating on Intuitive Surgical (ISRG)
July 19, 2024 6:31 AM EDTRBC Capital analyst Shagun Singh reiterated an Outperform rating and $475.00 price target on Intuitive Surgical (NASDAQ: ISRG)
The analyst comments "ISRG reported Q2'24 results, delivering upside surprise of 2% on sales driven by better-than-expected procedure volume growth (+17% vs. +15.5%) and system placements (341 vs. 318);... More
Intuitive Surgical (ISRG) PT Lowered to $410 at Evercore ISI
July 19, 2024 5:07 AM EDTEvercore ISI analyst Vijay Kumar lowered the price target on Intuitive Surgical (NASDAQ: ISRG) to $410.00 (from $425.00) while maintaining a In Line rating.
The analyst comments "Thesis Update: ISRG grew total rev by 14.5%, beating ST by ~190 bps this was driven by ~16% consumable rev growth, ~14% system and ~10% service rev growth. Consumable was driven by ~17% procedures growth (Beat ST by ~150 bps), and the CAGR vs 2019 being consistent QoQ. US procedures grew 14% despite bariatric declining -MSD (vs flat in 1Q24 & +10% in 4Q23), driven by strength in Ion (>80% growth) & general surgery. International came in better... More
Intuitive Surgical (ISRG) PT Raised to $469 at BTIG
July 19, 2024 4:58 AM EDTBTIG analyst Ryan Zimmerman raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $469.00 (from $459.00) while maintaining a Buy rating.
The analyst comments "We reiterate our Buy and raise our PT to $469 (from $459) following 2Q24 results. ISRG reported revenue of $2.009B (14.5% Y/Y) and adj. EPS of $1.78 vs. BTIG/Cons. estimates of $1.95B/$1.97B and adj. EPS of... More
